News and Trends 28 Jun 2017
UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic
Update (28/06/2017): Cellectis has announced the first administration of UCART123 in its Phase I trial in Acute Myeloid Leukemia. Update (07/02/2017): the FDA has granted Cellectis IND approval to start…